NDC 43538-300

CENTANY

Mupirocin

CENTANY is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Medimetriks Pharmaceuticals Inc. The primary component is Mupirocin.

Product ID43538-300_127980e2-98fd-4dfb-87a6-e8ed31f577e8
NDC43538-300
Product TypeHuman Prescription Drug
Proprietary NameCENTANY
Generic NameMupirocin
Dosage FormOintment
Route of AdministrationTOPICAL
Marketing Start Date2009-02-26
Marketing CategoryNDA / NDA
Application NumberNDA050788
Labeler NameMedimetriks Pharmaceuticals Inc
Substance NameMUPIROCIN
Active Ingredient Strength20 mg/g
Pharm ClassesRNA Synthetase Inhibitor Antibacterial [EPC],RNA Synthetase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43538-300-24

24 PACKET in 1 CARTON (43538-300-24) > .5 g in 1 PACKET (43538-300-99)
Marketing Start Date2009-02-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43538-300-24 [43538030024]

CENTANY OINTMENT
Marketing CategoryNDA
Application NumberNDA050788
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-02-26

NDC 43538-300-99 [43538030099]

CENTANY OINTMENT
Marketing CategoryNDA
Application NumberNDA050788
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-02-26

NDC 43538-300-30 [43538030030]

CENTANY OINTMENT
Marketing CategoryNDA
Application NumberNDA050788
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2009-02-26

Drug Details

Active Ingredients

IngredientStrength
MUPIROCIN20 mg/g

OpenFDA Data

SPL SET ID:90cfa2dc-3904-4bd3-b951-dcdb141883bf
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 106346
  • 404070

    • Pharmacological Class

    • RNA Synthetase Inhibitor Antibacterial [EPC]
    • RNA Synthetase Inhibitors [MoA]
    • RNA Synthetase Inhibitor Antibacterial [EPC]
    • RNA Synthetase Inhibitors [MoA]

    NDC Crossover Matching brand name "CENTANY" or generic name "Mupirocin"

    NDCBrand NameGeneric Name
    43538-300CENTANYmupirocin
    43538-310CentanyMupirocin
    0093-1010MupirocinMupirocin
    0168-0352Mupirocinmupirocin
    17856-0112mupirocinMupirocin
    21695-188Mupirocinmupirocin
    21922-029MupirocinMupirocin
    42254-137MupirocinMupirocin
    42254-229mupirocinMupirocin
    45802-018MUPIROCINmupirocin
    45802-112mupirocinMupirocin
    45865-722MupirocinMupirocin
    49999-644mupirocinMupirocin
    50090-0898MupirocinMupirocin
    50090-1587mupirocinMupirocin
    50090-1929MupirocinMupirocin
    50090-4349mupirocinMupirocin
    50090-4397mupirocinMupirocin
    50268-568MupirocinMupirocin
    50268-572mupirocinMupirocin
    50436-0025Mupirocinmupirocin
    50436-0112mupirocinMupirocin
    50436-0180MupirocinMupirocin
    50436-1010MupirocinMupirocin
    51672-1312MupirocinMupirocin
    52959-743mupirocinMupirocin
    53002-9850MupirocinMupirocin
    53002-9851MupirocinMupirocin
    53002-9852MupirocinMupirocin
    53002-9853mupirocinMupirocin
    55700-069MupirocinMupirocin
    55700-333MupirocinMupirocin

    Trademark Results [CENTANY]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CENTANY
    CENTANY
    78263336 3130516 Live/Registered
    PERRIGO ISRAEL PHARMACEUTICALS, LTD.
    2003-06-17
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.